Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer von Sedelaar, J.P.M., Israel, B., Debruyne, F.M.J.

Volltext

Estetrol improves quality of life in advanced castration-sensitive prostate cancer: A randomized clinical trial von Van Moorselaar, R.J.A., Coelingh Bennink, H.J.T., Debruyne, F.M.J.

Volltext

Endocrine approaches in the therapy of prostate carcinoma von d'Ancona, F.C.H., Debruyne, F.M.J.

Volltext

Precision Surgery and Genitourinary Cancers von Autorino, Riccardo, Porpiglia, Francesco, Dasgupta, Prokar, Rassweiler, Jens, Catto, James, Hampton, Lance J, Lima, Estevão, Mirone, Vincenzo, Derweesh, Ithaar, Debruyne, Frans M.J

Volltext

Transrectal and transperineal MRI-guided prostate cancer pathways in biopsy-naïve men von Israël, B., Immerzeel, J.J.F.M., Van Der Leest, M.M.G., Hannink, G.J., Zámecnik, P., Bomers, J.G.R., Schoots, I.G., Van Basten, J.P.A., Debruyne, F.M.J., Van Oort, I.M., Sedelaar, J.P.M., Barentsz, J.O.

Volltext

Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille calmette-guérin–RIVM and mitomycin c in superficial bladder cancer von Witjes, J.A., Meijden, A.P.M.v.d, Collette, L., Sylvester, R., Debruyne, F.M.J., van Aubel, A., Witjes, W.P.J.

Volltext

Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the international prostate symptom score von Ezz El Din, K., Kiemeney, L.A.L.M., De Wildt, M.J.A.M., Debruyne, F.M.J., De La Rosette, J.J.M.C.H.

Volltext

ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT von DEBRUYNE, F.M.J

Volltext bestellen

ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT von DEBRUYNE, F.M.J

Volltext bestellen

ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT von DEBRUYNE, F.M.J

Volltext bestellen

Intratumoral nuclear morphologic heterogeneity in prostate cancer von van der Poel, H.G., Oosterhof, G.O.N., Schaafsma, H.E., Debruyne, F.M.J., Schalken, J.A.

Volltext

Prostate-Specific Antigen as an Estimator of Prostate Volume in the Management of Patients with Symptomatic Benign Prostatic Hyperplasia von Mochtar, C.A, Kiemeney, L.A.L.M, van Riemsdijk, M.M, Barnett, G.S, Laguna, M.P, Debruyne, F.M.J, de la Rosette, J.J.M.C.H

Volltext

ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT von DEBRUYNE, F.M.J

Volltext bestellen

ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT von DEBRUYNE, F.M.J

Volltext bestellen

Sustained-Release Alfuzosin, Finasteride and the Combination of Both in the Treatment of Benign Prostatic Hyperplasia von Debruyne, F.M.J., Jardin, A., Colloi, D., Resel, L., Witjes, W.P.J., Delauche-Cavallier, M.C., McCarthy, C., Geffriaud-Ricouard, C.

Volltext

239 Testosterone treatment is not associated with increased risk of prostate cancer or cardiovascular events: Results from the Registry of Hypogonadism in Men (RHYME) von Debruyne, F.M.J, Schröder, F.H, Roehrborn, C.G, Maggi, M, Jones, T.H, Behre, H.M, Jackson, G, Cunningham, G.R, Dobs, A.S, Brown, O.A, Finn, J.D, Wu, F.C.W, Rosen, R.C

Volltext

ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT von DEBRUYNE, F.M.J

Volltext bestellen

ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT von DEBRUYNE, F.M.J

Volltext bestellen

Factors affecting recurrence and progression in superficial bladder tumours von Kurth, K.H., Denis, L., Bouffioux, Ch, Sylvester, R., Debruyne, F.M.J., Pavone-Macaluso, M., Oosterlinck, W.

Volltext

Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma von Beerlage, H.P, Thüroff, S, Debruyne, F.M.J, Chaussy, C, de la Rosette, J.J.M.C.H

Volltext